Fil LTD Kodiak Sciences Inc. Transaction History

Fil LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $1.55 Million - $2.02 Million	-18,906 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$110.45 - $164.47 $2.08 Million - $3.09 Million	18,797 Added 17244.95%	18,906 $2.14 Million
Q4 2020 Feb 08, 2021	SELL	$60.78 - $154.03 $4,680 - $11,860	-77 Reduced 41.4%	109 $16,000
Q3 2020 Nov 13, 2020	BUY	$45.05 - $59.27 $2,072 - $2,726	46 Added 32.86%	186 $11,000
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $1,837 - $2,848	43 Added 44.33%	140 $8,000
Q1 2020 May 14, 2020	BUY	$38.18 - $73.95 $3,703 - $7,173	97 New	97 $5,000

101

38.8M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $289M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.